Story · Nutrition

Orforglipron Cuts Sleep Apnea Burden by About Half

1 outlet · first reported by ConscienHealth 1d ago

Coverage, in order

  1. 1d ago
    ConscienHealth indie peer-reviewed
    Orforglipron Cuts Sleep Apnea Burden by About Half

    Obstructive sleep apnea (OSA) is another important complication of obesity that responds to treatment with incretin-based medicines. New research in JAMA provides compelling evidence that an oral GLP-1 medicine – orforglipron – can substantially improve this condition, even in people who are…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.